Drug recall · June 19, 2019
AMIKACIN SULFATE INJECTION recall
Why: Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
AMIKACIN SULFATE INJECTION, USP, 1 gram/4 mL (250 mg/ml), 4 mL vial, Rx only, Mfd. by: Emcure Pharmaceuticals, Ltd., Hinjawadi, Pune, India Mfd. for: Heritage Pharmaceuticals Inc.. NDC 23155-290-32
- Lots / codes
Lot: VEAC025, EXP 10-2019
- Quantity
- 14,960 4 mL vials
- Company
- Heritage Pharmaceuticals, Inc., East Brunswick, NJ
- Distribution
- Nationwide in the USA
- Initiated
- May 21, 2019 · Voluntary: Firm initiated
- Classified
- June 19, 2019
- Reported
- June 19, 2019
- Ended
- January 11, 2022
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amikacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.